Trials / Completed
CompletedNCT00035503
Multicenter Trial For Patients With Acute Crohn's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etiprednol dicloacetate |
Timeline
- Start date
- 2002-01-31
- Primary completion
- 2004-01-31
- Completion
- 2004-01-31
- First posted
- 2002-05-06
- Last updated
- 2021-12-08
Locations
11 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00035503. Inclusion in this directory is not an endorsement.